drugset / Trial / NCT06137469

Assessment of Gastric Emptying by SHR20004 in Healthy Subjects

NCT06137469

Phase 1 Completed 28 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedSingle-groupQuadruple-blindBasic science

Summary

The purpose of this study is to investigate the impact of SHR20004 on the pharmacokinetic (PK) characteristics of acetaminophen in healthy subjects.

Timeline

Start
2023-12-26
Primary completion
2024-03-16
Completion
2024-03-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule
Subject SHR20004 Unknown 0.15 mg Subcutaneous